A Phase II Study of S-1 plus Oxaliplatin for Patients with Recurrent Non-Squamous Cell Carcinoma of the Uterine Cervix (Tohoku Gynecologic Cancer Unit: TGCU206 Study)

A Phase II Study of S-1 plus Oxaliplatin for Patients with Recurrent Non-Squamous Cell Carcinoma of the Uterine Cervix (Tohoku Gynecologic Cancer Unit: TGCU206 Study)

Recurrent non-squamous cell carcinoma (non-SCC) of the uterine cervix is resistant to treatment and has a poor prognosis. The efficacy and safety of S-1/oxaliplatin (SOX) therapy in patients with recurrent non-SCC was examined in a phase II study. Fifteen patients were enrolled between August 2013 a...

Full description

Bibliographic Details
Main Authors: Takayuki Nagasawa, Tadahiro Shoji, Eriko Takatori, Yoshitaka Kaido, Masahiro Kagabu, Dai Shimizu, Tatsuhiko Shigeto, Tsukasa Baba, Toru Sugiyama, Yoshihito Yokoyama
Format: Article
Language:English
Published: MDPI AG 2023-10-01
Series:Cancers
Subjects:
cervical carcinoma
non-squamous cell carcinoma
recurrent
oxaliplatin
S-1
SOX
Online Access:https://www.mdpi.com/2072-6694/15/21/5201

Internet

https://www.mdpi.com/2072-6694/15/21/5201

Similar Items